I believe that Incyte will go down with Tuxo on FDA approval because clinical data from independent well know doctor showed servious safety issue. There is also not much medical benefit of it. Please read data published in the top medical journal, NEJM on Oct, 2011. The approval chance is very slim.
In addition, their newly approved drug have been sold much less than expected.
Market Data 
Markets 
AI
